Effects of cyclophosphamide on visceral leishmaniasis in the mouse.
D000818:Animals; D000906:Antibodies; D000917:Antibody Formation / Q000187:drug effects; D001769:Blood / Q000469:parasitology; D002908:Chronic Disease; D003520:Cyclophosphamide / Q000494:pharmacology*; D007106:Immune Sera; D007116:Immunization, Passive; D007156:Immunologic Memory; D007165:Immunosuppression Therapy; D007898:Leishmaniasis, Visceral / Q000276:immunology* / Q000469:parasitology; D008099:Liver / Q000469:parasitology; D008264:Macrophages / Q000469:parasitology; D051379:Mice; D013154:Spleen / Q000469:parasitology; D013997:Time Factors
D000906:Antibodies; D007106:Immune Sera; D003520:Cyclophosphamide